KTTA - Pasithea Therapeutics Corp.
0.831
-0.129 -15.523%
Share volume: 2,062,518
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.96
-0.13
-0.13%
Summary score
37%
Profitability
43%
Dept financing
20%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.93%
Return on assets
-12.54%
Return on sales
-11085.01%
Return on invested capital
17.62%
Total debt ratio
6.35%
Debt ratio change over timeo
-1.09%
Current Ratio
26.05%
Quick Ratio
36.22%
Cash Position Ratio
25.34%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-19.39%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
8.02%
Debt ratio change over timeo
0%
Current Ratio
8.23%
Quick Ratio
0%
Cash Position Ratio
7.73%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-21.98%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
7.98%
Debt ratio change over time
0%
Current Ratio
6.58%
Quick Ratio
0%
Cash Position Ratio
6.18%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-84.9%
Return on assets
-86.07%
Return on sales
-164.44%
Return on invested capital
-19.74%
Total debt ratio
-109.39%
Debt ratio change over time
-1.09%
Current Ratio
-21.29%
Quick Ratio
-21.29%
Cash Position Ratio
-20.32%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KTTA | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -8.93% | 14.82% | 9.25% | 0% |
| Return on assets | -12.54% | 4.21% | 3.01% | 0% |
| Return on sales | -11085.01% | 27.61% | 25.13% | 0% |
| Return on invested capital | 17.62% | 8.25% | 9.21% | 0% |
| Profitability | 25% | 87% | 69% | 0% |
| Total debt ratio | 6.35% | 81.46% | 59.72% | 0% |
| Debt ratio change over time | -1.09% | -9.8% | -49.67% | 0% |
| Dept financing | 2% | 25% | 18% | 25% |
| Current Ratio | 8.23% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 7.73% | 0.13% | 0.46% | 0% |
| Liquididy | 75% | 2% | 2% | 0% |
| Short-term ratios | KTTA | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -19.39% | 4.34% | 2.26% | 0% |
| Return on sales | 0% | 28.22% | 23.48% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 0% |
| Total debt ratio | 8.02% | 81.06% | 60.18% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 27% | 25% | 19% | 0% |
| Current Ratio | 8.23% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 7.73% | 0.13% | 0.46% | 0% |
| Liquididy | 50% | 29% | 28% | 0% |
